ArticleScientific reports2017

Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide.

Albin Jeanne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.